2017/1 GaBI Journal Table of Contents

Published in: Volume 6 / Year 2017 / Issue 1
Category: 2017/1 GaBI Journal Table of Contents
Visits: 236 total, 2 today

Contents

Editor’s Letter

Editor’s introduction to the initial issue of the sixth volume of GaBI Journal

Letters to the Editor

Pricing strategies for pharmaceuticals in developing countries: what options do we have?

Original Research

Naming and labelling of biologicals – a survey of US physicians’ perspectives

Review Article

Ocular emulsions and dry eye: a case study of a non-biological complex drug product delivered to a complex organ to treat a complex disease

Perspective

Pharmacovigilance of biosimilars and other biologicals within the hospital: current practices and future challenges

Special Report

Patent expiry dates for biologicals: 2016 update

Meeting Report

Roundtable on biosimilars: pharmacovigilance, traceability, immunogenicity, 15 November 2016, Madrid, Spain

Biosimilar product labels in Europe: what information should they contain?

Opinion

Austrian medicines authority positive towards biosimilar interchangeability

Pharma News

Top developments in biosimilars during 2016

Go Back Print

Leave a Reply